Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Anal Canal Carcinoma × Platinum × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Small Cell Lung Carcinoma 2 Non-squamous Non-small Cell Lung Cancer 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Uterine Cervical Neoplasms 1 Sertoli-Leydig Cell Tumor 1 Ovarian gynandroblastoma 1 Ovarian Neoplasms 1 Non-squamous NSCLC 1 Non-small Cell Lung Cancer Metastatic 1 Lung Neoplasms 1 Hypopharyngeal Neoplasms 1 Head and Neck Neoplasms 1 Granulosa cell tumor of the ovary 1 Gastrointestinal Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Brain Neoplasms 1 Anus Neoplasms 1 Anal Canal Carcinoma 1 Advanced Esophagus Cancer 1

Interventions

dehydroftorafur 1 Taxes 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Platinum 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Capecitabine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02560298 2023-06-22

InterAACT

Eastern Cooperative Oncology Group

Phase 2 Unknown

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡